Parallel Advisors’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-62
| Closed | -$149 | – | 3312 |
|
|
2023
Q4 | $149 | Hold |
62
| – | – | ﹤0.01% | 3198 |
|
|
2023
Q3 | $211 | Sell |
62
-33
| -35% | -$112 | ﹤0.01% | 3221 |
|
|
2023
Q2 | $698 | Buy |
95
+18
| +23% | +$132 | ﹤0.01% | 3023 |
|
|
2023
Q1 | $798 | Hold |
77
| – | – | ﹤0.01% | 3007 |
|
|
2022
Q4 | $909 | Buy |
77
+15
| +24% | +$177 | ﹤0.01% | 2921 |
|
|
2022
Q3 | $1K | Buy |
62
+35
| +130% | +$565 | ﹤0.01% | 2863 |
|
|
2022
Q2 | $1K | Sell |
27
-22
| -45% | -$815 | ﹤0.01% | 2726 |
|
|
2022
Q1 | $2K | Sell |
49
-153
| -76% | -$6.25K | ﹤0.01% | 2547 |
|
|
2021
Q4 | $9K | Buy |
202
+176
| +677% | +$7.84K | ﹤0.01% | 2138 |
|
|
2021
Q3 | $1K | Sell |
26
-24
| -48% | -$923 | ﹤0.01% | 2822 |
|
|
2021
Q2 | $3K | Buy |
50
+45
| +900% | +$2.7K | ﹤0.01% | 2423 |
|
|
2021
Q1 | $0 | Sell |
5
-16
| -76% | – | ﹤0.01% | 2803 |
|
|
2020
Q4 | $2K | Buy |
+21
| New | +$2K | ﹤0.01% | 2274 |
|
|
2020
Q3 | – | Sell |
-10
| Closed | – | – | 2561 |
|
|
2020
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 2498 |
|
|
2020
Q1 | – | Sell |
-114
| Closed | -$6K | – | 2431 |
|
|
2019
Q4 | $6K | Hold |
114
| – | – | ﹤0.01% | 1896 |
|
|
2019
Q3 | $6K | Sell |
114
-114
| -50% | -$6K | ﹤0.01% | 1839 |
|
|
2019
Q2 | $11K | Hold |
228
| – | – | ﹤0.01% | 1532 |
|
|
2019
Q1 | $12K | Hold |
228
| – | – | ﹤0.01% | 1436 |
|
|
2018
Q4 | $13K | Sell |
228
-6
| -3% | -$342 | ﹤0.01% | 1213 |
|
|
2018
Q3 | $15K | Buy |
+234
| New | +$15K | ﹤0.01% | 1257 |
|